Repare Therapeutics Inc (RPTX) — Capital Reinvestment Ratio
Latest as of September 2022:
0.00x
Repare Therapeutics Inc (RPTX) has a Capital Reinvestment Ratio of 0.00x as of September 2022, meaning it reinvests 0% of its operating cash flow ($88.16 Million) in capital expenditures ($266.00K). See Repare Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$88.16 Million
USD
Capital Expenditures
$266.00K
USD
Data as of
Sep 2022
Most recent filing
Repare Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Repare Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Repare Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Repare Therapeutics Inc from 2022 to 2022. For live market cap and broader valuation context, see RPTX stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 1.87x | $322.00K | $602.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow